109 related articles for article (PubMed ID: 10986077)
1. Synthesis of a beta1,2-mannopyranosyl tetrasaccharide found in the phosphomannan antigen of Candida albicans.
Nitz M; Purse BW; Bundle DR
Org Lett; 2000 Sep; 2(19):2939-42. PubMed ID: 10986077
[TBL] [Abstract][Full Text] [Related]
2. Design of a Candida albicans disaccharide conjugate vaccine by reverse engineering a protective monoclonal antibody.
Bundle DR; Nycholat C; Costello C; Rennie R; Lipinski T
ACS Chem Biol; 2012 Oct; 7(10):1754-63. PubMed ID: 22877569
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and immunochemical studies on a Candida albicans cluster glycoconjugate vaccine.
Wu X; Lipinski T; Carrel FR; Bailey JJ; Bundle DR
Org Biomol Chem; 2007 Nov; 5(21):3477-85. PubMed ID: 17943207
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of monodeoxy and mono-O-methyl congeners of methyl beta-D-mannopyranosyl-(1-->2)-beta-D-mannopyranoside for epitope mapping of anti-Candida albicans antibodies.
Nycholat CM; Bundle DR
Carbohydr Res; 2009 Mar; 344(5):555-69. PubMed ID: 19249752
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of a Candida albicans tetrasaccharide spanning the β1,2-mannan phosphodiester α-mannan junction.
Dang AT; Johnson MA; Bundle DR
Org Biomol Chem; 2012 Oct; 10(41):8348-60. PubMed ID: 22996034
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of di- to hexasaccharide 1,2-linked beta-mannopyranan oligomers, a terminal S-linked tetrasaccharide congener and the corresponding BSA glycoconjugates.
Nitz M; Bundle DR
J Org Chem; 2001 Dec; 66(25):8411-23. PubMed ID: 11735519
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of 3,6-branched oligomannoside fragments of the mannan from Candida albicans cell wall corresponding to the antigenic factor 4.
Karelin AA; Tsvetkov YE; Paulovicová L; Bystrický S; Paulovicová E; Nifantiev NE
Carbohydr Res; 2010 Jul; 345(10):1283-90. PubMed ID: 20096401
[TBL] [Abstract][Full Text] [Related]
8. Preparation of monoclonal antibodies reactive with beta-1,2-linked oligomannosyl residues in the phosphomannan-protein complex of Candida albicans NIH B-792 strain.
Tojo M; Shibata N; Kobayashi M; Mikami T; Suzuki M; Suzuki S
Clin Chem; 1988 Mar; 34(3):539-43. PubMed ID: 3280163
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of glycoconjugate vaccines for Candida albicans using novel linker methodology.
Wu X; Bundle DR
J Org Chem; 2005 Sep; 70(18):7381-8. PubMed ID: 16122263
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of antibody responses to cell wall mannan and a major cytoplasmic antigen of Candida albicans in rabbits and humans.
Jones JM
J Lab Clin Med; 1980 Nov; 96(5):845-60. PubMed ID: 6999104
[No Abstract] [Full Text] [Related]
11. Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies.
Han Y; Kanbe T; Cherniak R; Cutler JE
Infect Immun; 1997 Oct; 65(10):4100-7. PubMed ID: 9317014
[TBL] [Abstract][Full Text] [Related]
12. Nature of Candida albicans-derived carbohydrate antigen recognized by a monoclonal antibody in patient sera and distribution over Candida species.
Jacquinot PM; Plancke Y; Sendid B; Strecker G; Poulain D
FEMS Microbiol Lett; 1998 Dec; 169(1):131-8. PubMed ID: 9851044
[TBL] [Abstract][Full Text] [Related]
13. Different effects of native Candida albicans mannan and mannan-derived oligosaccharides on antigen-stimulated lymphoproliferation in vitro.
Podzorski RP; Gray GR; Nelson RD
J Immunol; 1990 Jan; 144(2):707-16. PubMed ID: 2153174
[TBL] [Abstract][Full Text] [Related]
14. Conformational analysis of β-1,2-linked mannobiose to mannoheptaose, specific antigen of pathogenic yeast Candida albicans.
Shibata N; Okawa Y
Chem Pharm Bull (Tokyo); 2010 Oct; 58(10):1386-90. PubMed ID: 20930409
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and immunological studies of glycoconjugates of Cryptococcus neoformans capsular glucuronoxylomannan oligosaccharide structures.
Oscarson S; Alpe M; Svahnberg P; Nakouzi A; Casadevall A
Vaccine; 2005 Jun; 23(30):3961-72. PubMed ID: 15917118
[TBL] [Abstract][Full Text] [Related]
16. A β-mannan trisaccharide conjugate vaccine aids clearance of Candida albicans in immunocompromised rabbits.
Lipinski T; Wu X; Sadowska J; Kreiter E; Yasui Y; Cheriaparambil S; Rennie R; Bundle DR
Vaccine; 2012 Sep; 30(44):6263-9. PubMed ID: 22902677
[TBL] [Abstract][Full Text] [Related]
17. Role of Candida albicans in granulomatous tissue reactions. I. In vitro degradation of C. albicans and immunospecificity of split products.
Meister H; Heymer B; Schäfer H; Haferkamp O
J Infect Dis; 1977 Feb; 135(2):224-34. PubMed ID: 320273
[TBL] [Abstract][Full Text] [Related]
18. Antigenic activity of the cell components of Candida albicans.
Tomsíková A; Vsikl D; Novácková D
Mykosen; 1976 Jun; 19(6):175-82. PubMed ID: 787782
[No Abstract] [Full Text] [Related]
19. [Immunological responses to cultural filtrates in guinea pigs sensitized to Aspergillus fumigatus and Candida albicans].
Suzuki M; Hayashi Y
Nihon Saikingaku Zasshi; 1975 Jul; 30(4):583-8. PubMed ID: 1104918
[No Abstract] [Full Text] [Related]
20. Immunochemical study on the mannans of Candida albicans NIH A-207, NIH B-792, and J-1012 strains prepared by fractional precipitation with cetyltrimethylammonium bromide.
Shibata N; Ichikawa T; Tojo M; Takahashi M; Ito N; Okubo Y; Suzuki S
Arch Biochem Biophys; 1985 Dec; 243(2):338-48. PubMed ID: 3002275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
